October 26, 2016
Horizon completes acquisition of Raptor
Horizon Pharma has completed the acquisition of Raptor Pharmaceutical…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
October 26, 2016
Novartis CEO sees tougher U.S. drug pricing over next three-five years
Novartis expects a more difficult pricing environment for drugs in…
October 26, 2016
AstraZeneca’s ovarian cancer tablets pass Phase III SOLO-2 trial
AstraZeneca’s Lynparza tablets against BRCA-mutated ovarian cancer have shown…
October 25, 2016
Novartis’s Q3 2016 net income $10,9B shorter than last year
Novartis’s Q3 2016 net income $10,9B shorter than last year
October 25, 2016
Allergan completes acquisition of Vitae
Allergan successfully completed its tender offer to purchase …
October 25, 2016
Bangladesh’s Beximco gets its second US FDA product approval
Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …
October 24, 2016
Astellas’s and Pfizer’s cancer drug gets new product label data
Astellas Pharma and Pfizer have announced the FDA approved a supplemental New …
October 24, 2016
FDA gives green light to Merck’s CDI drug
The US FDA has approved Merck’s Zinplava (bezlotoxumab) Injection 25 mg/mL, which …
October 24, 2016
Biophytis outsources AMD drug production to Patheon, USA
Biophytis has entered into an agreement with US firm Patheon for the industrial …
October 24, 2016
GSK applies to FDA for zoster vaccine
GlaxoSmithKline has submitted a Biologics License Application (BLA) for its candidate shingles vaccine, ShingrixTM, to the United States Food and Drug Administration (FDA).